In 2023, doctors in Kenya reported the country’s first genetically confirmed case of Chronic Granulomatous Disease. The infant had a harmful change in the CYBB  gene, but that variant did not appear in the major databases used to interpret genetic tests. As a result, the child’s doctors had little guidance from existing genomic resources, even though similar variants had already been studied in Europe, Asia, and North America. This is where genomic inclusion comes in. It mean